CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Dr. George Gunn Joins Argenta as Chairman of the Board of Directors

Life Sciences Review Life Sciences Review | Tuesday, May 25, 2021
Tweet

Argenta announces that Dr. George Gunn had been appointed as the company's new Chairman of the Board of Directors.


FREMONT, CA: Argenta, the world's leading CRO and CDMO focused on animal health, has announced that Dr. George Gunn had been appointed as the company's new Chairman of the Board of Directors. He takes over for David Geor, who will continue to represent Argenta's Board of Directors. The change follows the finalization of KKR's acquisition of Argenta earlier this year.


George Gunn, a veterinarian, has worked in the animal health industry for many years. George established Stonehaven Consulting AG in 2015, a global life science consulting company with extensive experience in the animal health industry. Earlier, he worked for Novartis for 12 years, where he was a member of the Executive Committee since 2008. George was President of Pharmacia Animal Health for three years before joining Novartis, and he worked for Johnson & Johnson for 15 years before that. George began his career as a private practice veterinarian and then as a field veterinarian for the United Kingdom Ministry of Agriculture, concentrating on the regulation of zoonotic and economic diseases.


"I am delighted to become Chairman of the Board and to serve Argenta at this important stage in its development. The team has done a good job so far and the strong partnership with KKR enables the company to accelerate its growth strategy, continue to provide high-quality animal health technology as well as services, and build on the vision for Argenta as a global animal health service company," commented George Gunn.


"Georges long history of leadership, experience, and insights in the animal health industry make him an ideal person for this role," said Kugan Sathiyanandarajah, Managing Director at KKR, on behalf of Argenta's shareholders. "I look forward to working closely with him to continue to ensure Argenta makes a positive impact for its customers, its people, and the broader animal health community."


"I would like to thank David Geor for his leadership and the valuable contributions he has made to Argenta. In every interaction throughout the last 12 years, David has led with the best interest of Argenta and its employees firmly in mind, and I am pleased that he continues to be part of our Board," said Ben Russell, CEO of Argenta. 


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/dr-george-gunn-joins-argenta-as-chairman-of-the-board-of-directors-nwid-375.html